Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Tag
  • N-6xHis
    (1)
  • N-His
    (1)
TargetMol | Tags By Expression System
  • E. coli
    (1)
  • P. pastoris (Yeast)
    (1)
TargetMol | Tags By Species
  • Human
    (1)
  • Mouse
    (1)
TargetMol | Tags By SPR-compatible Buffer
  • Buffer exchange required
    (1)
  • Ready-to-use
    (1)
Filter
Search Result
Results for "

nqo1

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    24
    TargetMol | Inhibitors_Agonists
  • Natural Products
    6
    TargetMol | Natural_Products
  • Recombinant Protein
    2
    TargetMol | Recombinant_Protein
  • Antibody Products
    1
    TargetMol | Antibody_Products
TargetMolTargetMolCompare
NQO1 Protein, Human, Recombinant (His)
QR1, NMORI, NMOR1, NAD(P)H dehydrogenase, quinone 1, DTD, DIA4, DHQU
TMPY-03407
NQO1 gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. NQO1 forms homodimers and reduces quinones to hydroquinones. NQO1's enzymatic activity prevents the one-electron reduction of quinones that results in the production of radical species. Mutations in the NQO1 gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of NQO1 has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized. Recent pharmacological research suggests the feasibility of genotype-directed redox chemotherapeutic intervention targeting NQO1 breast cancer, a common missense genotype encoding a functionally impaired NQO1 protein.
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer